Biljana Jekić

Association of the TYMS 3G/3G genotype with poor response and GGH 354GG genotype with the bone marrow toxicity of the methotrexate in RA patients

Biljana Jekić, Ljiljana Luković, Vera Bunjevački et al. · European Journal of Clinical Pharmacology · 2012 · 52 citations

Hematological Malignancy, Bone Marrow Failure, Autoimmune Disease +10

Bcl‐2 Expression in Oral Squamous Cell Carcinoma

Branka Popović, Biljana Jekić, Ivana Novaković et al. · Annals of the New York Academy of Sciences · 2007 · 40 citations

Cancer genes alterations and HPV infection in oral squamous cell carcinoma

Branka Popović, Biljana Jekić, Ivana Novaković et al. · International Journal of Oral and Maxillofacial Surgery · 2010 · 38 citations

Cancer Genes Alterations, Human Papillomavirus Vaccines, Oral Cavity +10

Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models

Barbara Jenko, Matija Tomšič, Biljana Jekić et al. · Frontiers in Pharmacology · 2018 · 32 citations · Full text

Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis.

Vera Milic, Biljana Jekić, Ljiljana Luković et al. · PubMed · 2012 · 31 citations